Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

COXISTAC 12% GRANULAR DIN 02237631

Status: Marketed
Holder: PHIBRO ANIMAL HEALTH CORPORATION
Molecule: SALINOMYCIN SODIUM

Health Canada record

Active ingredient(s)SALINOMYCIN SODIUM 120 G
Dosage formDrug Premix
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date04-May-1999
Current status date16-Feb-2017
SourceHealth Canada DPD

Establishment licence of the holder

Phibro Animal Health Ltd. — licence 3-002901, currently licensed, last inspection rating I (2026-06-23).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SALINOMYCIN SODIUM

DINProductCompanyFormStrengthStatus
02246692BIO-COX 120G PLUSHUVEPHARMA EOODDrug PremixSALINOMYCIN SODIUM 120 GMarketed
00884545COXISTAC 6%PHIBRO ANIMAL HEALTH CORPORATIONDrug PremixSALINOMYCIN SODIUM 60 GMarketed
00603724POSISTAC 6%PHIBRO ANIMAL HEALTH CORPORATIONDrug PremixSALINOMYCIN SODIUM 60 GMarketed
02230508SACOX 120HUVEPHARMA EOODDrug PremixSALINOMYCIN SODIUM 120 GMarketed
02266709BIO-COX 120 GALPHARMA CANADA CORPORATIONDrug PremixSALINOMYCIN SODIUM 120 GCancelled Post Market
00703478P 25/2 VIT GRIL MED (COXISTAC) FMX 4.8GM/KGLA COOP FEDEREEDrug PremixSALINOMYCIN SODIUM 4.8 GCancelled Post Market
02237431SALINOMYCIN 60 PREMIXBIO AGRI MIX LPDrug PremixSALINOMYCIN SODIUM 60 GDormant

Notices of Compliance

NOCDateSubmissionReason
189822017-02-16Supplement to a New Drug Submission (SNDS)CHANGE FROM POWDER TO GRANULAR FORM
109492010-01-21New Drug Submission (NDS)Change in ownership
62452001-04-02New Drug Submission (NDS)
67111998-03-20New Drug Submission (NDS)
Request a quote for COXISTAC 12% GRANULAR

How to read a Canadian DIN record